Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

January 1, 2025

Conditions
SepsisLiver Dysfunction
Interventions
DRUG

Mecobalamin

The drug Mecobalamin in the intervention group was divided into intravenous and oral formulations, with the intravenous formulation being used for the first 14 days of the experiment and the oral formulation for the second 14 days.

DRUG

Ceftriaxone Sodium

Ceftriaxone sodium all intravenous formulations

DRUG

Saline

The saline used in the control group was the same as the saline used in the experimental group to dispense the drug

DRUG

Placebo

Placebo and Mecobalamin tablets look and smell the same.

Trial Locations (1)

Unknown

Sichuan Provincial People's Hospital, Chengdu

All Listed Sponsors
lead

Sichuan Provincial People's Hospital

OTHER